Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 21 cases
Iván Guerra, Alicia Algaba, José Lázaro Pérez‐Calle, et al.
Journal of Crohn s and Colitis (2011) Vol. 6, Iss. 5, pp. 518-523
Open Access | Times Cited: 99

Showing 1-25 of 99 citing articles:

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
Fernando Magro, Paolo Gionchetti, Rami Eliakim, et al.
Journal of Crohn s and Colitis (2017) Vol. 11, Iss. 6, pp. 649-670
Open Access | Times Cited: 1660
Drugs for Autoimmune Inflammatory Diseases: From Small Molecule Compounds to Anti-TNF Biologics
Ping Li, Ying Zheng, Xin Chen
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 301
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, et al.
Gut (2013) Vol. 63, Iss. 4, pp. 567-577
Open Access | Times Cited: 285
Generalized pustular psoriasis: a review and update on treatment
Karl M. Hoegler, A.M. John, Marc Z. Handler, et al.
Journal of the European Academy of Dermatology and Venereology (2018) Vol. 32, Iss. 10, pp. 1645-1651
Closed Access | Times Cited: 174
Aktualisierte S3-Leitlinie – „Diagnostik und Therapie des Morbus Crohn“ 2014
J. Preiß, Bernd Bokemeyer, H. J. Buhr, et al.
Zeitschrift für Gastroenterologie (2014) Vol. 52, Iss. 12, pp. 1431-1484
Closed Access | Times Cited: 183
Dermatological adverse reactions during anti-TNF treatments: Focus on inflammatory bowel disease
Giammarco Mocci, Manuela Marzo, Alfredo Papa, et al.
Journal of Crohn s and Colitis (2013) Vol. 7, Iss. 10, pp. 769-779
Open Access | Times Cited: 136
Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)
M. Pérez-de-Lis, Soledad Retamozo, Alejandra Flores-Chávez, et al.
Expert Opinion on Drug Safety (2017) Vol. 16, Iss. 11, pp. 1255-1271
Open Access | Times Cited: 129
Cumulative Incidence of, Risk Factors for, and Outcome of Dermatological Complications of Anti-TNF Therapy in Inflammatory Bowel Disease: A 14-Year Experience
E. Fréling, Cédric Baumann, Jean-François Cuny, et al.
The American Journal of Gastroenterology (2015) Vol. 110, Iss. 8, pp. 1186-1196
Closed Access | Times Cited: 119
Induction or exacerbation of psoriatic lesions during anti-TNF-α therapy for inflammatory bowel disease: A systematic literature review based on 222 cases
Rafael Denadai, Fábio Vieira Teixeira, Flávio Steinwurz, et al.
Journal of Crohn s and Colitis (2012) Vol. 7, Iss. 7, pp. 517-524
Open Access | Times Cited: 115
Paradoxical psoriasis in a large cohort of patients with inflammatory bowel disease receiving treatment with anti-TNF alpha: 5-year follow-up study
Daniela Pugliese, Luisa Guidi, Pietro Manuel Ferraro, et al.
Alimentary Pharmacology & Therapeutics (2015) Vol. 42, Iss. 7, pp. 880-888
Open Access | Times Cited: 107
TNF Inhibitor-Induced Psoriasis: Proposed Algorithm for Treatment and Management
Sara J. Li, Lourdes M. Pérez-Chada, Joseph F. Merola
Journal of Psoriasis and Psoriatic Arthritis (2018) Vol. 4, Iss. 2, pp. 70-80
Open Access | Times Cited: 95
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004
Andreas Sturm, Andreas Stallmach, Raja Atreya, et al.
Zeitschrift für Gastroenterologie (2022) Vol. 60, Iss. 03, pp. 332-418
Closed Access | Times Cited: 66
Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline
Andreas Sturm, Raja Atreya, Dominik Bettenworth, et al.
Zeitschrift für Gastroenterologie (2024) Vol. 62, Iss. 08, pp. 1229-1318
Open Access | Times Cited: 9
New insights into the dichotomous role of innate cytokines in gut homeostasis and inflammation
Giorgos Bamias, Daniele Corridoni, Theresa T. Pizarro, et al.
Cytokine (2012) Vol. 59, Iss. 3, pp. 451-459
Open Access | Times Cited: 99
Altered redox status in the blood of psoriatic patients: involvement of NADPH oxidase and role of anti-TNF-α therapy
Victoria Barygina, Matteo Becatti, Gemma Soldi, et al.
Redox Report (2013) Vol. 18, Iss. 3, pp. 100-106
Open Access | Times Cited: 77
Generalized pustular psoriasis – a model disease for specific targeted immunotherapy, systematic review
Alexander Boehner, Alexander A. Navarini, Kilian Eyerich
Experimental Dermatology (2018) Vol. 27, Iss. 10, pp. 1067-1077
Open Access | Times Cited: 77
Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease
Iván Guerra, Tamara Pérez-Jeldres, Marisa Iborra, et al.
Inflammatory Bowel Diseases (2016) Vol. 22, Iss. 4, pp. 894-901
Open Access | Times Cited: 75
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines
Valentina Andretto, Silvia Dusi, Serena Zilio, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115080-115080
Closed Access | Times Cited: 18
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
Gordon W. Moran, Allen Lim, Jennifer Bailey, et al.
Alimentary Pharmacology & Therapeutics (2013) Vol. 38, Iss. 9, pp. 1002-1024
Open Access | Times Cited: 68
IL-36γ Sustains a Proinflammatory Self-amplifying Loop with IL-17C in Anti-TNF–induced Psoriasiform Skin Lesions of Patients with Crohnʼs Disease
Matthias Friedrich, Cornelia Tillack, Andreas Wollenberg, et al.
Inflammatory Bowel Diseases (2014) Vol. 20, Iss. 11, pp. 1891-1901
Closed Access | Times Cited: 64
Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis
Clémentine Perrier, Gert De Hertogh, Jonathan Cremer, et al.
Inflammatory Bowel Diseases (2012) Vol. 19, Iss. 2, pp. 246-253
Open Access | Times Cited: 62
Skin Reactions During Anti-TNFα Therapy for Pediatric Inflammatory Bowel Disease
Tarja Mälkönen, Anne Puustinen, Kaarina Heiskanen, et al.
Inflammatory Bowel Diseases (2014) Vol. 20, Iss. 8, pp. 1309-1315
Open Access | Times Cited: 56
TNF-α inhibitor–induced psoriasis: A decade of experience at the Cleveland Clinic
Sean Mazloom, Di Yan, Jeffery Hu, et al.
Journal of the American Academy of Dermatology (2018) Vol. 83, Iss. 6, pp. 1590-1598
Closed Access | Times Cited: 55
Digestive system in psoriasis: an update
Daniel Pietrzak, Aldona Pietrzak, Dorota Krasowska, et al.
Archives of Dermatological Research (2017) Vol. 309, Iss. 9, pp. 679-693
Open Access | Times Cited: 54
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease (2017) Vol. 49, Iss. 4, pp. 338-358
Open Access | Times Cited: 50
Page 1 - Next Page

Scroll to top